Novel Resistance Mechanisms to Second-Generation EGFR Tyrosine Kinase Inhibitor Afatinib and Associations With Genomic Features in NSCLC. [PDF]
Lin F +8 more
europepmc +1 more source
Effects of thymidylate synthase inhibitors differ in genomic uracilation and mutagenic potential. [PDF]
Holub E +7 more
europepmc +1 more source
Mutational signatures in hematological malignancies. [PDF]
Sartori FA +3 more
europepmc +1 more source
Effective in vivo RNA base editing via engineered cytidine deaminase APOBECs fused with PUF proteins. [PDF]
Han W +10 more
europepmc +1 more source
Ethnic genomic diversity in esophageal squamous cell carcinoma. [PDF]
Li WM, Jiao Y, Liu SQ, Wang CX, He M.
europepmc +1 more source
Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial. [PDF]
Kityo C +20 more
europepmc +1 more source
Molecular and immune characteristics of neuroendocrine bladder carcinoma - Implications for diagnosis, prognosis, and therapy: A review. [PDF]
Zhang T, Zhang X, Qian L, Hu C, Li J.
europepmc +1 more source
Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance. [PDF]
Wensing AM +8 more
europepmc +1 more source
Genomic Characterization of Lung Cancer in Never-Smokers Using Deep Learning. [PDF]
Saha M +20 more
europepmc +1 more source

